Bio Protocol vs Synthetix — how do they compare? Bio Protocol trades at Rp431.39 (market cap Rp982,16M, Rp150,34M 24h volume), while Synthetix trades at Rp3,516 (market cap Rp1,19T, Rp82,43M 24h volume). The key difference: Synthetix is far larger — about 1211.6× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Synthetix's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Synthetix for 68 Days on average.
| BIO | SNX | |
|---|---|---|
Market Cap | Rp982,16M | Rp1,19T |
Volume (24h) | Rp150,34M | Rp82,43M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 344,5M SNX |
Typical Hold Time | 18 Days | 68 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Synthetix (SNX) is currently trading at Rp3,544 with a market cap of Rp1.21 trillion, showing bearish technical signals overall despite oscillators suggesting some bullish momentum. The token faces strong resistance at Rp3,584 with support at Rp3,438, indicating a tight trading range. Recent network activity shows moderate adoption with 68-day average hold time, though specific protocol updates are limited.
Overall outlook remains cautious due to bearish technical dominance. Key opportunities include potential oversold bounce from current levels, while major risks involve continued selling pressure and limited fundamental catalysts. Investors should monitor DeFi ecosystem developments and trading volume patterns for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SNX is a decentralized finance (DeFi) protocol that provides on-chain exposure to various crypto and non-crypto assets. The platform allows users to trade and exchange highly liquid synthetic assets (synths) autonomously.
Read more on SNX →